Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation

Abstract

A recently identified class of signaling factors uses critical cysteine motif(s) that act as redox-sensitive ‘sulfhydryl switches’ to reversibly modulate specific signal transduction cascades regulating downstream proteins with similar redox-sensitive sites. For example, signaling factors such as redox factor-1 (Ref-1) and transcription factors such as the AP-1 complex both contain redox-sensitive cysteine motifs that regulate activity in response to oxidative stress. The mammalian thioredoxin reductase-1 (TR) is an oxidoreductase selenocysteine-containing flavoprotein that also appears to regulate multiple downstream intracellular redox-sensitive proteins. Since ionizing radiation (IR) induces oxidative stress as well as increases AP-1 DNA-binding activity via the activation of Ref-1, the potential roles of TR and thioredoxin (TRX) in the regulation of AP-1 activity in response to IR were investigated. Permanently transfected cell lines that overexpress wild type TR demonstrated constitutive increases in AP-1 DNA-binding activity as well as AP-1-dependent reporter gene expression, relative to vector control cells. In contrast, permanently transfected cell lines expressing a TR gene with the active site cysteine motif deleted were unable to induce AP-1 activity or reporter gene expression in response to IR. Transient genetic overexpression of either the TR wild type or dominant-negative genes demonstrated similar results using a transient assay system. One mechanism through which TR regulates AP-1 activity appears to involve TRX sub-cellular localization, with no change in the total TRX content of the cell. These results identify a novel function of the TR enzyme as a signaling factor in the regulation of AP-1 activity via a cysteine motif located in the protein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Abate C, Patel L, Rauscher III FJ, Curran T . 1990 Science 249: 1157–1161

  • Abate C, Marshak DR, Curran T . 1991 Oncogene 6: 2179–2185

  • Becker K, Gromer S, Schirmer RH, Müller S . 2000 Eur. J. Biochem. 267: 6118–6125

  • Beetz A, Peter RU, Oppel T, Kaffenberger W, Rupec RA, Meyer M, van Beuningen D, Kind P, Messer G . 2000 Int. J. Radiat. Biol. 76: 1443–1453

  • Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G . 1996 Anticancer Res. 16: 3459–3466

  • Curry HA, Clemens RA, Shah S, Bradbury CM, Botero A, Goswami P, Gius D . 1999 J. Biol. Chem. 274: 23061–23067

  • Dignam JD . 1990 Meth. Enzymol. 182: 194–203

  • Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaka PY, Berggren M, Briehl MM, Powis G . 1996 Cancer Res. 56: 5765–5770

  • Franza Jr BR, Rauscher III FJ, Josephs SF, Curran T . 1988 Science 239: 1150–1153

  • Gius D, Cao XM, Rauscher III FJ, Cohen DR, Curran T, Sukhatme VP . 1990 Mol. Cell. Biol. 10: 4243–4255

  • Hallahan DE, Gius D, Kuchibhotla J, Sukhatme V, Kufe DW, Weichselbaum RR . 1993 J. Biol. Chem. 268: 4903–4907

  • Halliwell B, Gutteridge JM . 1988 Hum. Toxicol. 7: 7–13

  • Halliwell B, Gutteridge JM . 1990 Methods Enzymol. 186: 1–85

  • Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, Yodoi J . 1999 J. Biol. Chem 274: 27891–27897

  • Hirota K, Matsui M, Murata M, Takashima Y, Cheng FS, Itoh T, Fukuda K, Yodoi J . 2000a Biochem. Biophys. Res. Comm. 274: 177–182

  • Hirota K, Nakamura H, Arai T, Ishii H, Bai J, Itoh T, Fukuda K, Yodoi J . 2000b Biochem. Biophys. Res. Comm. 275: 825–830

  • Holbrook NJ, Fornace Jr AJ . 1991 New Biol. 3: 825–833

  • Holmgren A, Bjornstedt M . 1995 Meth. Enzymol. 252: 199–208

  • Hu J, Ma X, Lindner DJ, Karra S, Hofmann ER, Reddy SP, Kalvakolanu DV . 2001 Oncogene 20: 4235–4248

  • Karin M, Smeal T . 1992 Trends Biochem. Sci 17: 418–422

  • Kerppola T, Curran T . 1995 Nature 373: 199–200

  • Kerr LD, Inoue J, Verma IM . 1992 Curr. Opin. Cell Biol. 4: 496–501

  • Kirkpatrick DL, Ehrmantraut G, Stettner S, Kunkel M, Powis G . 1997 Oncol. Res. 9: 351–356

  • Maity A, McKenna WG, Muschel RJ . 1994 Radiother. Oncol. 31: 1–13

  • Ma X, Karra S, Lindner DJ, Hu J, Reddy SP, Kimchi A, Yodoi J, Kalvakolanu DV . 2001 Oncogene 20: 3703–3715

  • Martin M, Vozenin MC, Gault N, Crechet F, Pfarr CM, Lefaix JL . 1997 Oncogene 18: 981–989

  • Mustacich D, Powis G . 2000 Biochem. J. 346: 1–8

  • Oberley TD, Verwiebe E, Zhong W, Kang SW, Rhee SG . 2001 Free Radic. Biol. Med. 30: 412–424

  • Poole LB, Reynolds CM, Wood ZA, Karplus PA, Ellis HR, Calzi ML . 2000 Eur. J. Biochem. 267: 6126–6133

  • Powis G, Kirkpatrick DL, Angulo M, Baker A . 1998 Chem. Biol. Interact. 112: 23–34

  • Sasada T, Sono H, Yodoi J . 1996 J. Toxicol. Sci. 21: 285–287

  • Spitz DR, Sim JE, Ridnour LA, Galoforo SS, Lee YJ . 2000 Ann. NY Acad. Sci. 899: 349–362

  • Storz G, Tartaglia LA, Ames BN . 1990 Science 248: 189–194

  • Tuttle SW, Varnes ME, Mitchell JB, Biaglow JE . 1992 Int. J. Radiat. Onc. Biol. Phys. 22: 671–675

  • Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J, Gius D . 2000 Cancer Res. 60: 6688–6695

  • Williams CH, Arscott DL, Müller S, Lennon BW, Ludwig ML, Wang PM, Veine DM, Becker K, Heiner Schirmer R . 2000 Eur. J. Biochem. 267: 6110–6119

  • Xanthoudakis S, Curran T . 1992 EMBO J. 11: 653–664

  • Xanthoudakis S, Miao G, Wang F, Pan Y-C, Curran T . 1992 EMBO J. 11: 3323–3335

  • Xanthoudakis S, Curran T . 1996 Adv. Exp Med. Biol. 387: 69–75

Download references

Acknowledgements

The authors are indebted to Dr Jeffery Russell for the invaluable technical expertise offered at stages throughout this project. D Gius was supported by grants from the National Institute of Health (1 K08 CA72602-01), and the American Cancer Society (ACS-IRG-58-010-43 and ACS RPG-00-292-01-TBE). DR Spitz was supported by NIH R01 HL51469. NIH CA69593 supported P Goswami. DV Kalvakolanu was supported by grants from the National Institute of Health (R01 CA 78282 and CA 71401).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Gius.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karimpour, S., Lou, J., Lin, L. et al. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 21, 6317–6327 (2002). https://doi.org/10.1038/sj.onc.1205749

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205749

Keywords

This article is cited by

Search

Quick links